ULTRAGENYX PHARMACEUTICAL INC. Common Stock, Value, Issued
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Common Stock, Value, Issued of $0 as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-05
- 2026-06-30: Common Stock, Value, Issued $0.00.
- 2026-03-31: Common Stock, Value, Issued $0.00.
- 2025-12-31: Common Stock, Value, Issued $0.00.
- 2025-09-30: Common Stock, Value, Issued $96.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $96.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $96.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $94.00K 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-18 | $92.00K 10-K · filed 2025-02-19 |
| 2024-09-30 | $92.00K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $92.00K 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $83.00K 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $82.00K 10-K · filed 2025-02-19 | |
| 2023-09-30 | $72.00K 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $71.00K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $71.00K 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $70.00K 10-K · filed 2024-02-21 | |
| 2022-09-30 | $70.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $70.00K 10-Q · filed 2022-07-29 | |
| 2022-03-31 | $70.00K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $69.00K 10-K · filed 2023-02-17 | |
| 2021-09-30 | $68.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $68.00K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $67.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $67.00K 10-K · filed 2022-02-15 | |
| 2020-09-30 | $61.00K 10-Q · filed 2020-10-27 | |
| 2020-06-30 | $60.00K 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $59.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $58.00K 10-K · filed 2021-02-12 | |
| 2019-09-30 | $58.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $58.00K 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $57.00K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $51.00K 10-K · filed 2020-02-14 | |
| 2018-09-30 | $51.00K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $50.00K 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $50.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $44.00K 10-K · filed 2019-02-20 | |
| 2017-09-30 | $42.00K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $42.00K 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $42.00K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $41.00K 10-K · filed 2018-02-21 | |
| 2016-09-30 | $40.00K 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $39.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $39.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $39.00K 10-K · filed 2017-02-17 | |
| 2015-09-30 | $39.00K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $36.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $36.00K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $32.00K 10-K · filed 2016-02-26 | |
| 2014-09-30 | $32.00K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $30.00K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $30.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $4.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |